论文部分内容阅读
近十余年对糖尿病在免疫学方面改变的研究,取得了比较大的进展,这些临床和实验研究的成果,对于从病因机制上将临床糖尿病区分为不同的两型,提供了有力的支持。正是在这一基础上1979年美国卫生部设立的一个关于糖尿病分型和命名的国际工作小组,和1980年WHO糖尿病专家委员会,对临床糖尿病提出了新的分型建议:胰岛素依赖型糖尿病(IDDM)—Ⅰ型和非胰岛素依赖型(NIDDM)—Ⅱ型。目前已有证据说明抗胰岛细胞的自体免疫,在IDDM的发病
Nearly ten years of diabetes in the immunological aspects of the study made considerable progress, the results of these clinical and experimental studies, from the etiology and pathogenesis of clinical diabetes divided into two different types, provided strong support. It is on this basis that an international working group on the typing and naming of diabetes, set up by the U.S. Department of Health in 1979, and the WHO Committee of Experts on Diabetes in 1980 made a new classification suggestion for clinical diabetes: insulin-dependent diabetes mellitus IDDM) -I and non-insulin-dependent (NIDDM) -II. There is evidence that anti-islet cell autoimmunity is present in IDDM